Please login to the form below
Austria
This page shows the latest Austria news and features for those working in and with pharma, biotech and healthcare.
Creative destruction
I say fascinating because he claimed to have set himself three goals in life: to be the greatest economist in the world, to be the best horseman in Austria and to
Latest news
-
Sandoz to invest €50m in Austrian manufacturing facility to meet global antibiotic demand
The announcement follows the company’s pledge in 2021 to commit over 100m in new manufacturing technology for the production of oral amoxicillin active pharmaceutical ingredient (API) at Kundl, Austria.
-
FlyPharma Conference Europe 2022 shares the latest supply chain challenges and advice for better industry collaboration
FlyPharma Europe will return for its seventh year in 2023 in Vienna, Austria.
-
Dexcom launches next-generation continuous glucose monitor for diabetes patients
Dexcom has announced the launch of its next-generation continuous glucose monitor (CGM) – Dexcom G7 – for people with diabetes aged two years and older in the UK, Ireland, Germany, Austria and
-
WHO announces recommended 2023 flu vaccines for southern hemisphere
2021 (H3N2)-like virus; a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus. ... The cell culture- or recombinant-based quadrivalent vaccines contain an A/Sydney/5/2021 (H1N1) pdm09-like virus
-
Novartis announces $300m investment to boost development of next-generation biotherapeutics
The multi-year investment will be implemented across the company’s existing locations in Switzerland, Slovenia and Austria. ... The multi-year investment will span both drug substance and drug product development and will be implemented across existing
More from news
Approximately 1 fully matching, plus 124 partially matching documents found.
Latest Intelligence
-
Attracting doctors to low-demand specialties
project. This global programme attracted candidates from Austria, Belgium, Canada, China, France, Italy, the Netherlands, Taiwan, the UK and the USA.
-
Market access in Europe: balancing access and affordability
The alliance has subsequently expanded to include Luxembourg and Austria, with Ireland expected to be the next country to become a member.
-
Charting a course for expansion
Germany and the UK are first, Austria, Denmark and the Netherlands are right there with us - it's really their timing that determines it, not just ours.
-
Immunisation politicised
Reshaping the HPV vaccine in Austria. While swift in other European countries, implementation took several years in Austria. ... to do so, Austria became a 'European frontrunner' in gender-neutral HPV vaccination.
-
Safe from harm?
In Germany (75%), Austria (71%), Canada (66%), Finland (65%) and the US (64%), patients were most likely to work with the physician so that both of them have input into decision.
More from intelligence
Approximately 1 fully matching, plus 13 partially matching documents found.
Latest appointments
-
Ashfield Engage appoints Serap Becker as head of patient solutions in DACH region
UDG Healthcare company Ashfield Engage has announced the appointment of Serap Becker (pictured above) as its new head of patient solutions in the DACH region (Austria, Germany, and Switzerland).
-
RSA boosts its German speaking divisions
Appoints Andreas Reimer and Ji Kwon. RSA has appointed Andreas Reimer and Ji Kwon (pictured) to strengthen its operations in Germany, Austria and Switzerland (DACH).
-
EMA elects Dr Christa Wirthumer-Hoche new vice chair
She has been involved in the European medicines regulatory network since 1995, when Austria joined the European Union, has was a member of the Coordination Group for Mutual Recognition and Decentralised
-
Arvato turns to Google for head of digital marketing
Monsees joins from Google, where he was most recently responsible for the automotive, consumer goods and healthcare divisions in Germany, Austria and Switzerland.
-
UCB’s chair Gerhard Mayr joins Almirall board
company OMV and the Bank of Austria.
More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
Random42 Bring Medical Animation to Bio-Europe Spring 2019
The convention runs from March 25th–27th and is being held at the Messe Wien Exhibition and Congress Center, Vienna, Austria.
-
Attracting doctors to low-demand specialties: A role for industry?
project. This global programme attracted candidates from Austria, Belgium, Canada, China, France, Italy, the Netherlands, Taiwan, the UK and the USA.
-
Plugging knowledge gaps to demonstrate the benefits of new medicines
Outcomes Research in Vienna, Austria.
-
Dr. Thomas Blatter has been appointed Vice President, DACH Region
From Anthill’s Freiburg office, Dr. Blatter will liaise with local affiliates of life science companies operating in Germany, Austria and Switzerland – helping them plan and execute digital marketing solutions that
-
Anthill expands its services in DACH region
Anthill, a digital communications agency focused on the life science industry, is expanding its services for local clients based in Germany, Austria and Switzerland.
More from PMHub
Approximately 1 fully matching, plus 7 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- Europe’s cancer community publishes new report on transforming patient care
- BeiGene’s Brukinsa receives FDA approval for chronic lymphocytic leukaemia
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Eli Lilly announces $450m investment in US manufacturing site
- EU outlines measures to mitigate antibiotic shortage across Europe
- Sanofi/Regeneron’s Dupixent recommended by CHMP for atopic dermatitis in children
- Bristol Myers Squibb’s plaque psoriasis treatment recommended by CHMP
- Sandoz’s high concentration Hyrimoz formulation recommended for use in EU
- ASH 2022: bad blood but big advances
- Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- Alzheimer’s Society urges UK government to deliver on dementia plan
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- Sanofi backs vaccines unit with €350m Canadian facility
- World Health Organization releases latest set of COVID-19 guidelines
- Omnichannel communications in Medical Affairs: closing the gap between aspiration and reality
PMHub
Nucleus Global
Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 950 experts delivering world-class...
Latest intelligence
- ASH 2022: bad blood but big advances
- Five trends from this year’s ASH conference – and why even pop icons can’t compete with the playlist of innovation shaping haematology...
- Virtual Steering Committee & Peer Influence Program
- In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
- Meeting healthcare’s rising challenges
- The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
